Cangrelor for heart blood flow during planned stent procedure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if cangrelor, a fast-acting blood thinner, can prevent small vessel damage during a planned stent placement in patients with stable chest pain. It may help improve blood flow to the heart muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have stable chest pain or a known chronic coronary condition
- You have not taken any P2Y12-inhibitor blood thinners (like clopidogrel, prasugrel, or ticagrelor) in the past
- You are scheduled for a routine stent procedure for a moderate narrowing in a main heart artery
- The narrowing is not severe (more than 90% blocked) and you do not have heart failure with very weak pumping function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of the blood thinner ticagrelor works better than clopidogrel in people with stable coronary artery disease who are getting a planned stent. It aims to find which drug is safer and more effective for preventing future heart problems.
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
This trial studies whether a medicine (nicorandil) given into a coronary artery during stent procedures can help keep blood flow from getting worse. It may help people having stent placement for coronary artery disease by improving how well blood moves through the treated area.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.